RFP
RYTM icon

Root Financial Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Root Financial Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.7K Sell
31
-12
-28% -$1.17K ﹤0.01% 2188
2025
Q4 		$4.6K Buy
+43
New +$4.56K ﹤0.01% 1786

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Root Financial Partners's RYTM Position: Q1 2026 in Review

Root Financial Partners reduced its Rhythm Pharmaceuticals (RYTM) stake by 28% in Q1 2026, selling an estimated $1.17K and leaving 31 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2188.

Root Financial Partners first reported a position in RYTM in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.6K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Root Financial Partners held 31 shares of Rhythm Pharmaceuticals worth $2.7K as of Q1 2026.
  • Root Financial Partners sold 12 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $1.17K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2188 holding.
  • Root Financial Partners first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Root Financial Partners's Rhythm Pharmaceuticals position peaked at $4.6K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.